Rezolute, Inc. (RZLT)
4.02
+0.15
(+3.88%)
USD |
NASDAQ |
Nov 10, 16:00
4.015
0.00 (0.00%)
After-Hours: 20:00
Rezolute Price : 4.02 for Nov. 10, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 10, 2026 | 3.93 | 4.205 | 3.90 | 4.02 | 1.605M |
| Nov 09, 2026 | 3.99 | 4.20 | 3.79 | 3.87 | 2.463M |
| Nov 06, 2026 | 3.67 | 3.90 | 3.59 | 3.88 | 1.521M |
| Nov 05, 2026 | 3.93 | 3.97 | 3.564 | 3.64 | 1.228M |
| Nov 04, 2026 | 4.12 | 4.34 | 3.95 | 3.96 | 1.074M |
| Nov 03, 2026 | 3.94 | 4.130 | 3.90 | 4.01 | 919347.0 |
| Nov 02, 2026 | 3.98 | 4.02 | 3.745 | 3.88 | 845175.0 |
| Oct 30, 2026 | 4.05 | 4.160 | 3.88 | 3.95 | 779253.0 |
| Oct 29, 2026 | 4.20 | 4.330 | 4.075 | 4.12 | 756260.0 |
| Oct 28, 2026 | 4.11 | 4.24 | 4.02 | 4.22 | 1.415M |
| Oct 27, 2026 | 3.80 | 4.14 | 3.778 | 4.11 | 1.400M |
| Oct 26, 2026 | 3.87 | 3.89 | 3.73 | 3.82 | 1.544M |
| Oct 23, 2026 | 3.78 | 3.938 | 3.70 | 3.855 | 1.198M |
| Oct 22, 2026 | 3.67 | 3.965 | 3.67 | 3.86 | 1.356M |
| Oct 21, 2026 | 3.70 | 3.785 | 3.645 | 3.70 | 930013.0 |
| Oct 20, 2026 | 3.66 | 3.840 | 3.63 | 3.70 | 1.226M |
| Oct 19, 2026 | 3.62 | 3.72 | 3.37 | 3.70 | 1.779M |
| Oct 16, 2026 | 3.90 | 3.99 | 3.56 | 3.58 | 1.398M |
| Oct 15, 2026 | 4.25 | 4.33 | 3.90 | 3.90 | 2.120M |
| Oct 14, 2026 | 4.52 | 4.70 | 4.21 | 4.23 | 1.703M |
| Oct 13, 2026 | 4.825 | 4.85 | 4.56 | 4.61 | 1.508M |
| Oct 12, 2026 | 4.86 | 4.91 | 4.72 | 4.87 | 1.010M |
| Oct 09, 2026 | 4.60 | 4.91 | 4.55 | 4.87 | 1.874M |
| Oct 08, 2026 | 4.33 | 4.685 | 4.32 | 4.64 | 2.198M |
| Oct 07, 2026 | 4.29 | 4.56 | 4.23 | 4.38 | 1.690M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Opus Genetics, Inc. | 4.23 |
| ACADIA Pharmaceuticals, Inc. | 18.28 |
| Alnylam Pharmaceuticals, Inc. | 151.64 |
| Anika Therapeutics, Inc. | 13.47 |
| Savara, Inc. | 4.92 |
Price Related Metrics
| Price to Book Value | 4.524 |
| Earnings Yield | -18.59% |
| Market Cap | 388.82M |